Inggris -
Inggris -
MHRA (Medicines & Healthcare Products Regulatory Agency)
enalapril 10mg tablets
de pharmaceuticals - enalapril maleate - oral tablet - 10mg
Inggris -
Inggris -
MHRA (Medicines & Healthcare Products Regulatory Agency)
enalapril 20mg tablets
de pharmaceuticals - enalapril maleate - oral tablet - 20mg
Inggris -
Inggris -
MHRA (Medicines & Healthcare Products Regulatory Agency)
enalapril 10mg tablets
sigma pharmaceuticals plc - enalapril maleate - oral tablet - 10mg
Inggris -
Inggris -
MHRA (Medicines & Healthcare Products Regulatory Agency)
enalapril 10mg tablets
mawdsley-brooks & company ltd - enalapril maleate - oral tablet - 10mg
Inggris -
Inggris -
MHRA (Medicines & Healthcare Products Regulatory Agency)
enalapril 20mg tablets
mawdsley-brooks & company ltd - enalapril maleate - oral tablet - 20mg
Inggris -
Inggris -
MHRA (Medicines & Healthcare Products Regulatory Agency)
enalapril 10mg tablets
bristol laboratories ltd - enalapril maleate - oral tablet - 10mg
Inggris -
Inggris -
MHRA (Medicines & Healthcare Products Regulatory Agency)
enalapril 20mg tablets
bristol laboratories ltd - enalapril maleate - oral tablet - 20mg
Inggris -
Inggris -
MHRA (Medicines & Healthcare Products Regulatory Agency)
enalapril 10mg tablets
noumed life sciences ltd - enalapril maleate - oral tablet - 10mg
Inggris -
Inggris -
MHRA (Medicines & Healthcare Products Regulatory Agency)
enalapril 20mg tablets
noumed life sciences ltd - enalapril maleate - oral tablet - 20mg
Australia -
Inggris -
Department of Health (Therapeutic Goods Administration)
dbl ergometrine injection ergometrine maleate injection
pfizer australia pty ltd - ergometrine maleate, quantity: 500 microgram/ml - injection, solution - excipient ingredients: maleic acid; water for injections - prophylaxis ergometrine is administered after the delivery of the placenta for the purpose of contracting the uterus in order to prevent postpartum haemorrhage and postabortion haemorrhage due to uterine atony. treatment ergometrine is administered after the delivery of the placenta to promote involution of the uterus in order to treat postpartum haemorrhage and postabortion haemorrhage.